HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men.

Gordon Mansergh, Kenneth Mayer, Sabina Hirshfield, Rob Stephenson, Patrick Sullivan
Author Information
  1. Gordon Mansergh: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  2. Kenneth Mayer: The Fenway Institute, Fenway Health, Boston, Massachusetts.
  3. Sabina Hirshfield: Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
  4. Rob Stephenson: Department of Systems, Population, and Leadership, School of Nursing, University of Michigan, Ann Arbor.
  5. Patrick Sullivan: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Abstract

No abstract text available.

References

  1. J Acquir Immune Defic Syndr. 2010 Oct;55(2):e14-6 [PMID: 20859085]
  2. Sex Transm Infect. 2011 Oct;87(6):510 [PMID: 21873470]
  3. JMIR Res Protoc. 2019 Nov 15;8(11):e16439 [PMID: 31730043]
  4. J Int AIDS Soc. 2020 Mar;23(3):e25461 [PMID: 32153119]

Grants

  1. P30 AI060354/NIAID NIH HHS

MeSH Term

Anti-Retroviral Agents
Cross-Sectional Studies
HIV Infections
Humans
Pre-Exposure Prophylaxis
Sexual and Gender Minorities

Chemicals

Anti-Retroviral Agents

Word Cloud

Created with Highcharts 10.0.0MenHIVPre-exposureProphylaxisMedicationSharingAmongHIV-NegativeSex

Similar Articles

Cited By